We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 41-60 of 3,826 results
  1. Anodal HD-tDCS on the dominant anterior temporal lobe and dorsolateral prefrontal cortex: clinical results in patients with mild cognitive impairment

    Objectives

    Mild cognitive impairment (MCI) is a neurocognitive disorder in which the cognitive and mental abilities of humans are declined....

    Soheila Rezakhani, Mahmood Amiri, ... Vahid Sheibani in Alzheimer's Research & Therapy
    Article Open access 03 February 2024
  2. 27-hydroxycholesterol causes cognitive deficits by disturbing Th17/Treg balance and the related immune responses in mild cognitive impairment patients and C57BL/6J mice

    Background

    Cognitive impairment is associated with dysregulated immune responses. Emerging evidence indicates that Th17 cells and their characteristic...

    Tao Wang, Wen**g Feng, ... Rong **ao in Journal of Neuroinflammation
    Article Open access 19 December 2023
  3. Disentangling in-vivo microstructural changes of white and gray matter in mild cognitive impairment and Alzheimer’s disease: a systematic review and meta-analysis

    The microstructural characteristics of white and gray matter in mild cognitive impairment (MCI) and the early-stage of Alzheimer’s disease (AD)...

    Shuchang Zhong, **g**g Lou, ... Jie Zhang in Brain Imaging and Behavior
    Article 27 September 2023
  4. Hippocampus-centred grey matter covariance networks predict the development and reversion of mild cognitive impairment

    Background

    Mild cognitive impairment (MCI) has been thought of as the transitional stage between normal ageing and Alzheimer’s disease, involving...

    Mingxi Dang, Caishui Yang, ... Zhanjun Zhang in Alzheimer's Research & Therapy
    Article Open access 02 February 2023
  5. Beta to theta power ratio in EEG periodic components as a potential biomarker in mild cognitive impairment and Alzheimer’s dementia

    Background

    Alzheimer’s dementia (AD) is associated with electroencephalography (EEG) abnormalities including in the power ratio of beta to theta...

    Hamed Azami, Christoph Zrenner, ... Tarek K. Rajji in Alzheimer's Research & Therapy
    Article Open access 07 August 2023
  6. Neural biomarker diagnosis and prediction to mild cognitive impairment and Alzheimer’s disease using EEG technology

    Background

    Electroencephalogram (EEG) has emerged as a non-invasive tool to detect the aberrant neuronal activity related to different stages of...

    Bin Jiao, Rihui Li, ... Lu Shen in Alzheimer's Research & Therapy
    Article Open access 10 February 2023
  7. Behavioral Interventions in Mild Cognitive Impairment (MCI): Lessons from a Multicomponent Program

    Comparative effectiveness of behavioral interventions to mitigate the impacts of degeneration-based cognitive decline is not well understood. To...

    Shellie-Anne Levy, Glenn Smith, ... Melanie Chandler in Neurotherapeutics
    Article 01 January 2022
  8. Atrophy asymmetry in hippocampal subfields in patients with Alzheimer’s disease and mild cognitive impairment

    Volumetric analysis of hippocampal subfields and their asymmetry assessment recently has been useful biomarkers in neuroscience. In this study,...

    Amir Reza Jahanshahi, Reza Naghdi Sadeh, Davood Khezerloo in Experimental Brain Research
    Article 02 January 2023
  9. The Early Stage of Abnormal Aging: Cognitive Impairment

    Cognitive impairment has become an important aspect affecting the health and quality of life of middle-aged and elderly people, which is defined as...
    Huajie Shang, Chang Xu, ... Junying Zhang in Cognitive Aging and Brain Health
    Chapter 2023
  10. Evolution of brain network dynamics in early Parkinson’s disease with mild cognitive impairment

    How mild cognitive impairment (MCI) is instantiated in dynamically interacting and spatially distributed functional brain networks remains an...

    Chunguang Chu, Zhen Zhang, ... **aodong Zhu in Cognitive Neurodynamics
    Article 17 August 2022
  11. Parkinson’s disease CA2-CA3 hippocampal atrophy is accompanied by increased cholinergic innervation in patients with normal cognition but not in patients with mild cognitive impairment

    Although brain cholinergic denervation has been largely associated with cognitive decline in patients with Parkinson’s disease (PD), new evidence...

    Camille Legault-Denis, Étienne Aumont, ... Marc-André Bédard in Brain Imaging and Behavior
    Article 13 March 2024
  12. Disruption of early visual processing in amyloid-positive healthy individuals and mild cognitive impairment

    Background

    Amyloid deposition is a primary predictor of Alzheimer’s disease (AD) and related neurodegenerative disorders. Retinal changes involving...

    Daniel C. Javitt, Antigona Martinez, ... Yaakov Stern in Alzheimer's Research & Therapy
    Article Open access 28 February 2023
  13. Convergent Neuroimaging and Molecular Signatures in Mild Cognitive Impairment and Alzheimer’s Disease: A Data-Driven Meta-Analysis with N = 3,118

    The current study aimed to evaluate the susceptibility to regional brain atrophy and its biological mechanism in Alzheimer’s disease (AD). We...

    **aopeng Kang, Dawei Wang, ... Yong Liu in Neuroscience Bulletin
    Article Open access 01 June 2024
  14. Effects of computerized cognitive training on structure‒function coupling and topology of multiple brain networks in people with mild cognitive impairment: a randomized controlled trial

    Background

    People with mild cognitive impairment (MCI) experience a loss of cognitive functions, whose mechanism is characterized by aberrant...

    **gsong Wu, Youze He, ... Tatia M. C. Lee in Alzheimer's Research & Therapy
    Article Open access 23 September 2023
  15. Hippocampus-based static functional connectivity map** within white matter in mild cognitive impairment

    Mild cognitive impairment (MCI) is clinically characterized by memory loss and cognitive impairment closely associated with the hippocampal atrophy....

    Yuan Jiang, Pan Wang, ... Bharat B. Biswal in Brain Structure and Function
    Article 22 July 2022
  16. Detection of mild cognitive impairment in Parkinson’s disease using gradient boosting decision tree models based on multilevel DTI indices

    Background

    Cognitive dysfunction is the most common non-motor symptom in Parkinson’s disease (PD), and timely detection of a slight cognitive decline...

    Boyu Chen, Ming Xu, ... Guo Guang Fan in Journal of Translational Medicine
    Article Open access 08 May 2023
  17. Medication management and treatment adherence in Parkinson's disease patients with mild cognitive impairment

    Introduction

    The key feature that distinguishes mild cognitive impairment (MCI) from dementia is the absence of significant functional decline because...

    Betul Sumbul-Sekerci, Hasmet A. Hanagasi, ... Murat Emre in Acta Neurologica Belgica
    Article 24 March 2022
  18. Volume changes of hippocampal and amygdala subfields in patients with mild cognitive impairment and Alzheimer’s disease

    Background

    Automated segmentation of hippocampal and amygdala subfields could improve classification accuracy of Mild Cognitive Impairments (MCI) and...

    Hang Qu, Haitao Ge, ... Chunhong Hu in Acta Neurologica Belgica
    Article 12 April 2023
  19. Semantic fluency deficits and associated brain activity in Parkinson’s disease with mild cognitive impairment

    People living with Parkinson’s disease (PD) with poor verbal fluency have an increased risk of develo** dementia. This study examines the neural...

    Jihyun Yang, Katie L McMahon, ... Nadeeka N Dissanayaka in Brain Imaging and Behavior
    Article Open access 16 July 2022
  20. Plasma adiponectin levels predict cognitive decline and cortical thinning in mild cognitive impairment with beta-amyloid pathology

    Background

    Blood adiponectin and leptin are adipokines that emerged as potential biomarkers for predicting Alzheimer’s disease (AD) owing to their...

    Keun You Kim, Junghee Ha, ... Eosu Kim in Alzheimer's Research & Therapy
    Article Open access 04 November 2022
Did you find what you were looking for? Share feedback.